Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

Condition:   Parkinson's Disease Interventions:   Drug: Pimavanserin;   Other: Placebo;   Drug: Quetiapine Sponsor:   ACADIA Pharmaceuticals Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials